Phio Pharmaceuticals (PHIO) FCF Margin (QoQ) (2012 - 2018)
Phio Pharmaceuticals (PHIO) FCF Margin (QoQ) (2012 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.29 Bn | 131.44 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.31 Bn | 78.32 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.22 Bn | 60.03 Bn | 1.37 Bn |
| 4 | Moderna | 58.92 Bn | 53.78 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.07 Bn | 36.97 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.70 Bn | 28.39 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.99 Bn | 9.60 Bn | 668.28 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - |
| 10 | Phio Pharmaceuticals | 13.82 Mn | 13.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | -31,416.00 |
| Jun 30, 2018 | 508,441.00 |
| Mar 31, 2018 | 638,203.00 |
| Jun 30, 2016 | 858,333.00 |
| Mar 31, 2015 | 563,361.00 |
| Dec 31, 2014 | -32,589.00 |
| Sep 30, 2014 | 567,708.00 |
| Jun 30, 2014 | -860,144.00 |
| Mar 31, 2014 | -313,793.00 |
| Dec 31, 2013 | -318,527.00 |
| Sep 30, 2013 | -96,992.00 |
| Jun 30, 2013 | 121,452.00 |
| Mar 31, 2013 | 76,170.00 |
| Dec 31, 2012 | -67,947.00 |